Summary

Global Single-Cell Multi-Omics Market Industry Overview

The global single-cell multi-omics market is projected to reach $7.72 billion by 2033 from $1.43 billion in 2022, growing at a CAGR of 17.27% during the forecast period 2023-2033. The market is driven by factors such as a rise in the number of large-scale genomics studies leveraging single-cell RNA sequencing (Sc-RNA), use of the single-cell multi-omics approach for screening and diagnostics of diseases leading to a shift toward personalized medicine, and the increasing use of single-cell multi-omics for drug development.

Market Lifecycle Stage

The global single-cell multi-omics market is developing. The global single-cell multi-omics market has witnessed several collaborations among the market players. The collaborations are aimed at combining capabilities, expanding the customer base, and marketing, among others.

The opportunity for growth of the global single-cell multi-omics market lies in expansion into new research applications, such as single-cell metabolomics.

Impact of COVID-19

The COVID-19 pandemic has significantly impacted the world's healthcare sector, especially the single-cell multi-omics sector. The pandemic has caused changes in research priorities, supply chain interruptions, and regulatory process modifications that may have had an impact on the operations and activities of single-cell multi-omics.

The future impact of COVID-19 on the demand and supply across the global single-cell multi-omics market depends on the abilities of stakeholders to withstand unforeseeable scenarios in the future. The intensity of impact due to COVID-19 in the future will depend on the current efforts being made by companies to equip their supply chains with the necessary components and processes to remain responsive.

Market Segmentation:

Segmentation 1: by Sample Type
• Animal Sample
• Human Sample
• Microbial Sample

The global single-cell multi-omics market (by sample type) is expected to be dominated by the human sample segment.

Segmentation 2: by Techniques
• Single-Cell Isolation and Dispensing
• Single-Cell Analysis

The global single-cell multi-omics market (by techniques) is expected to be dominated by single-cell isolation and dispensing.

Segmentation 3: By Omics Type
• Single-Cell Transcriptomics
• Single-Cell Genomics
• Single-Cell Proteomics

The global single-cell multi-omics market (by omics type) is expected to be dominated by single-cell transcriptomics.

Segmentation 4: By Product Type
• Kits and Consumables
• Instruments
• Software

The global single-cell multi-omics market (by product type) is expected to be dominated by kits and consumables.

Segmentation 5: By Applications
• Clinical Research
• Translational Research
• Synthetic Biology

The global single-cell multi-omics market (by application) is expected to be dominated by clinical research.

Segmentation 6: By End User
• Biopharmaceutical and Biotech Companies
• Academic and Research Institutions
• Contract Research Organizations (CROs)

The global single-cell multi-omics market (by end user) is expected to be dominated by academic and research institutions.

Segmentation 7: by Region
• North America - U.S., Canada
• Europe - Germany, U.K., France, Italy, Spain, and Rest-of-Europe
• Asia-Pacific - China, Japan, India, Australia, Singapore, and Rest-of-Asia-Pacific
• Latin America - Brazil, Mexico, and Rest-of-Latin America
• Rest-of-the-World

The global single-cell multi-omics market (by region) is dominated by the North America region.

Recent Developments in Global Single-Cell Multi-Omics Market

• In February 2023, Singleron Biotechnologies and Macrogen Europe announced a strategic alliance to deliver outstanding single-cell multi-omics sequencing solutions, and they combined their strengths.
• In February 2023, Becton, Dickinson and Company announced a new instrument for single-cell multi-omics analysis that would enable scientists to run high-throughput studies without sacrificing sample integrity – potentially accelerating time to discovery across a wide range of disciplines, including immunology, genetic disease research, and cancer and chronic disease research.
• In December 2022, 10x Genomics, Inc. announced the first commercial shipments of its Xenium platform for in situ analysis. Xenium is the next generation of targeted spatial profiling of genes and proteins at subcellular resolution.
• In March 2023, Mission Bio partnered with the National Science Foundation (NSF) Engineering Research Center for Cell Manufacturing Technologies (CMaT), leveraging its Tapestri Platform to improve analytical assays and cell manufacturing processes.
• In December 2022, Mission Bio partnered with Abiosciences to co-develop bioinformatics packages for translational and clinical research applications in hematological cancers in China. The goal is to combine Mission Bio’s single-cell DNA and multi-omics capabilities with Abiosciences’ artificial intelligence technology to uncover new disease signatures and address therapeutic resistance.

Demand - Drivers and Limitations

The following are the drivers for the global single-cell multi-omics market:

• Rising Number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (Sc-RNA)
• Use of Single-Cell Multi-Omics Approach for Screening and Diagnostics of Diseases Leading to Shift Toward Personalized Medicine
• Increasing Use of Single-Cell Multi-Omics for Drug Development
• Collaborations among Technology Providers and Life Sciences Companies for Accelerating the Research in Single-Cell Multi-Omics

The market is expected to face some limitations as well due to the following challenges:

• High Cost of Single-Cell Analysis and Sequencing
• Limited Availability of Large Online Data Storage and Analysis Platforms

How can this report add value to an organization?

Growth/Marketing Strategy: The global single-cell multi-omics market has seen major development by key players operating in the market, such as new offerings, partnerships, collaboration, and joint ventures.

Competitive Strategy: The global single-cell multi-omics market has witnessed growth in recent years; as the field of single-cell multi-omics grows, it has witnessed increased collaboration between researchers, academic institutions, and industry partners to drive innovation and commercialization of these technologies. Single-cell multi-omics technologies are already being used in a variety of applications, such as cancer research, immunology, and neuroscience. As the technologies continue to improve, they may be applied to other areas of research, such as developmental biology and stem cell research.

Key Companies Profiled

• 10x Genomics, Inc.
• Becton, Dickinson and Company
• BICO GROUP AB (PUBL)
• Bio-Rad Laboratories, Inc.
• BGI Group
• Illumina Inc.
• Fluidigm Corporation
• Menarini Group
• Mission Bio
• Nanostring Technologies, Inc.
• Namocell, Inc.
• PhenomeX,inc.
• QIAGEN NV
• Rarecells Diagnostics
• Scipio Bioscience
• Shilps Sciences
• Singleron Biotechnologies
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
• Universal Sequencing Technology Corporation

ページTOPに戻る

Table of Contents

1 Market
1.1 Global Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.2 Market Overview
1.2.1 Key Findings
1.2.2 Current Market Scenario
1.2.2.1 For Researchers
1.2.2.2 For Diagnostics
1.3 Industry Outlook
1.3.1 Regulatory Framework
1.3.2 Patent Analysis
1.3.2.1 Awaited Technological Developments
1.3.2.2 Patent Filing Trend (by Country)
1.3.2.3 Patent Filing Trend (by Year)
1.3.3 Key Trends
1.3.3.1 Advancements in Imaging Techniques for Single-Cell Sequencing
1.3.3.2 Use of Artificial Intelligence (AI) and Machine Learning (ML) in Single-Cell Multi-Omics
1.3.3.3 Increased Development of Advanced Solution Based on Single-Cell Technology
1.3.4 Opportunity Assessment
1.3.5 Product Benchmarking
1.3.6 Clinical Trials
1.4 COVID-19 Impact
1.4.1 Pre-COVID-19
1.4.2 During COVID-19
1.4.3 Post COVID-19
1.5 Business Dynamics
1.5.1 Impact Analysis
1.5.2 Business Drivers
1.5.2.1 Rising Number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (Sc-RNA)
1.5.2.2 Use of Single-Cell Multi-Omics Approach for Screening and Diagnostics of Diseases Leading to Shift Toward Personalized Medicine
1.5.2.3 Increasing Use of Single-Cell Multi-Omics for Drug Development
1.5.2.4 Collaborations among Technology Providers and Life Sciences Companies for Accelerating the Research in Single-Cell Multi-Omics
1.5.3 Business Restraints
1.5.3.1 High Cost of Single-Cell Analysis and Sequencing
1.5.3.2 Limited Availability of Large Online Data Storage and Analysis Platforms
1.5.4 Business Opportunities
1.5.4.1 Expansion into New Research Applications, Such as Single-Cell Metabolomics
1.5.4.2 Increasing Adoption of Genomic-Based Medicine in Emerging Nations
2 Global Single-Cell Multi-Omics Market (by Product Type)
2.1 Overview
2.2 Instruments
2.3 Kits and Consumables
2.4 Software
3 Global Single-Cell Multi-Omics Market (by Sample Type)
3.1 Overview
3.2 Human Samples
3.2.1 Cancer Tissues
3.2.2 Stem Cells
3.2.3 Brain Cells
3.2.4 Immune Cells
3.2.5 Other Samples
3.3 Animal Samples
3.4 Microbial Samples
4 Global Single-Cell Multi-Omics Market (by Techniques)
4.1 Overview
4.2 Single-Cell Isolation and Dispensing
4.2.1 Fluorescence-Activated Cell Sorting (FACS)
4.2.2 Manual Cell Picking
4.2.3 Magnetic-Activated Cell Sorting (MACS)
4.2.4 Laser Capture Microdissection
4.2.5 Random Seeding
4.2.6 Microfluidics
4.2.7 Others
4.3 Single-Cell Analysis
4.3.1 Mass Cytometry
4.3.2 Polymerase Chain Reaction
4.3.3 Next-Generation Sequencing
4.3.4 Mass Spectrometry
4.3.5 Others
5 Global Single-Cell Multi-Omics Market (by Applications)
5.1 Overview
5.2 Clinical Research
5.2.1 Oncology
5.2.2 Immunology
5.2.3 Neurology
5.2.4 Cell Therapy
5.2.5 Cell Biology
5.2.6 Others
5.3 Translational Research
5.4 Synthetic Biology
6 Global Single-Cell Multi-Omics Market (by Omics Type)
6.1 Overview
6.2 Single-Cell Genomics
6.3 Single-Cell Proteomics
6.4 Single-Cell Transcriptomics
7 Global Single-Cell Multi-Omics Market (by End User)
7.1 Opportunity Assessment
7.2 Biopharmaceutical and Biotech Companies
7.3 Research and Academic Laboratories
7.4 Contract Research Organizations (CROs)
8 Global Single-Cell Multi-Omics Market (by Region)
8.1 North America
8.1.1 Key Findings and Opportunity Assessment
8.1.2 Market Dynamics
8.1.2.1 Impact Analysis
8.1.3 Market Sizing and Forecast
8.1.3.1 North America Single-Cell Multi-Omics Market (by Country)
8.1.3.1.1 U.S.
8.1.3.1.2 Canada
8.2 Europe
8.2.1 Key Findings and Opportunity Assessment
8.2.2 Market Dynamics
8.2.2.1 Impact Analysis
8.2.3 Market Sizing and Forecast
8.2.3.1 Europe Single-Cell Multi-Omics Market (by Country)
8.2.3.1.1 Germany
8.2.3.1.2 Italy
8.2.3.1.3 U.K.
8.2.3.1.4 Spain
8.2.3.1.5 France
8.2.3.1.6 Rest-of-Europe
8.3 Asia-Pacific
8.3.1 Key Findings and Opportunity Assessment
8.3.2 Market Dynamics
8.3.2.1 Impact Analysis
8.3.3 Sizing and Forecast Analysis
8.3.3.1 Asia-Pacific Single-Cell Multi-Omics Market (by Country)
8.3.3.1.1 China
8.3.3.1.2 Japan
8.3.3.1.3 India
8.3.3.1.4 Singapore
8.3.3.1.5 Australia
8.3.3.1.6 Rest-of-Asia-Pacific
8.4 Latin America
8.4.1 Key Findings and Opportunity Assessment
8.4.2 Market Dynamics
8.4.2.1 Impact Analysis
8.4.3 Sizing and Forecast Analysis
8.4.3.1 Latin America Single-Cell Multi-Omics Market (by Country)
8.4.3.1.1 Brazil
8.4.3.1.2 Mexico
8.4.3.1.3 Rest-of-Latin America
8.5 Rest-of-the-World
8.5.1 Key Findings
8.5.2 Market Dynamics
8.5.2.1 Impact Analysis
8.5.3 Market Sizing and Forecast
9 Markets - Competitive Benchmarking & Company Profiles
9.1 Competitive Benchmarking
9.1.1 Key Strategies and Developments
9.1.1.1 Funding Activities
9.1.1.2 New Offerings
9.1.1.3 Mergers and Acquisitions
9.1.1.4 Partnership, Collaboration, and Business Expansion
9.1.2 Market Share Analysis
9.1.3 Growth Share Analysis
9.1.3.1 By Application
9.1.3.2 By Omics Type
9.1.3.3 By Product Type
9.1.4 Visual Graphics of the Companies
9.1.5 Multi-Omics Ecosystem Active Players
9.2 Company Profiles
9.2.1 10x Genomics, Inc.
9.2.1.1 Company Overview
9.2.1.2 Role of 10x Genomics, Inc. in the Global Single-Cell Multi-Omics Market
9.2.1.3 Financials
9.2.1.4 Recent Developments
9.2.1.5 Analyst Perspective
9.2.2 Becton, Dickinson and Company
9.2.2.1 Company Overview
9.2.2.2 Role of Becton, Dickinson and Company in the Global Single-Cell Multi-Omics Market
9.2.2.3 Financials
9.2.2.4 Recent Developments
9.2.2.5 Analyst Perspective
9.2.3 BICO GROUP AB (PUBL)
9.2.3.1 Company Overview
9.2.3.2 Role of BICO GROUP AB (PUBL)in the Global Single-Cell Multi-Omics Market
9.2.3.3 Financials
9.2.3.4 Analyst Perspective
9.2.4 Bio-Rad Laboratories, Inc.
9.2.4.1 Company Overview
9.2.4.2 Role of Bio-Rad Laboratories, Inc. in the Global Single-Cell Multi-Omics Market
9.2.4.3 Financials
9.2.4.4 Analyst Perspective
9.2.5 BGI Group
9.2.5.1 Company Overview
9.2.5.2 Role of BGI Group in the Global Single-Cell Multi-Omics Market
9.2.5.3 Financials
9.2.5.4 Analyst Perspective
9.2.6 Illumina Inc.
9.2.6.1 Company Overview
9.2.6.2 Role of Illumina Inc. in the Global Single-Cell Multi-Omics Market
9.2.6.3 Financials
9.2.6.4 Analyst Perspective
9.2.7 Fluidigm Corporation (Standard Bio Tools)
9.2.7.1 Company Overview
9.2.7.2 Role of Fluidigm Corporation in the Global Single-Cell Multi-Omics Market
9.2.7.3 Financials
9.2.7.4 Recent Developments
9.2.7.5 Analyst Perspective
9.2.8 Menarini Group
9.2.8.1 Company Overview
9.2.8.2 Role of Menarini Group in the Global Single-Cell Multi-Omics Market
9.2.8.3 Analyst Perspective
9.2.9 Mission Bio
9.2.9.1 Company Overview
9.2.9.2 Role of Mission Bio in the Global Single-Cell Multi-Omics Market
9.2.9.3 Recent Developments
9.2.9.4 Analyst Perspective
9.2.10 Nanostring Technologies, Inc.
9.2.10.1 Company Overview
9.2.10.2 Role of Nanostring Technologies, Inc. in the Global Single-Cell Multi-Omics Market
9.2.10.3 Financials
9.2.10.4 Analyst Perspective
9.2.11 Namocell, Inc.
9.2.11.1 Company Overview
9.2.11.2 Role of Namocell, Inc. in the Global Single-Cell Multi-Omics Market
9.2.11.3 Analyst Perspective
9.2.12 PhenomeX,inc.
9.2.12.1 Company Overview
9.2.12.2 Role of PhenomeX,inc. in the Global Single-Cell Multi-Omics Market
9.2.12.3 Financials
9.2.12.4 Recent Developments
9.2.12.5 Analyst Perspective
9.2.13 QIAGEN NV
9.2.13.1 Company Overview
9.2.13.2 Role of QIAGEN NV in the Global Single-Cell Multi-Omics Market
9.2.13.3 Financials
9.2.13.4 Analyst Perspective
9.2.14 Rarecells Diagnostics
9.2.14.1 Company Overview
9.2.14.2 Role of Rarecells Diagnostics in the Global Single-Cell Multi-Omics Market
9.2.14.3 Analyst Perspective
9.2.15 Scipio Bioscience
9.2.15.1 Company Overview
9.2.15.2 Role of Scipio Bioscience in the Global Single-Cell Multi-Omics Market
9.2.15.3 Analyst Perspective
9.2.16 Shilps Sciences
9.2.16.1 Company Overview
9.2.16.2 Role of Shilps Sciences in the Global Single-Cell Multi-Omics Market
9.2.16.3 Analyst Perspective
9.2.17 Singleron Biotechnologies
9.2.17.1 Company Overview
9.2.17.2 Role of Singleron Biotechnologies in the Global Single-Cell Multi-Omics Market
9.2.17.3 Recent Developments
9.2.17.4 Analyst Perspective
9.2.18 Takara Bio Inc.
9.2.18.1 Company Overview
9.2.18.2 Role of Takara Bio Inc. in the Global Single-Cell Multi-Omics Market
9.2.18.3 Financials
9.2.18.4 Analyst Perspective
9.2.19 Thermo Fisher Scientific Inc.
9.2.19.1 Company Overview
9.2.19.2 Role of Thermo Fisher Scientific Inc. in the Global Single-Cell Multi-Omics Market
9.2.19.3 Financials
9.2.19.4 Analyst Perspective
9.2.20 Universal Sequencing Technology Corporation
9.2.20.1 Company Overview
9.2.20.2 Role of Universal Sequencing Technology Corporation in the Global Single-Cell Multi-Omics Market
9.2.20.3 Analyst Perspective
List of Figures
Figure 1: An Overview of Single-Cell Multi-Omics Sequencing Technologies
Figure 2: Global Single-Cell Multi-Omics Market, Impact Analysis
Figure 3: Global Single-Cell Multi-Omics Market (by Application), % Share, 2022 and 2033
Figure 4: Global Single-Cell Multi-Omics Market (by Region), $Billion, 2022 and 2033
Figure 5: Global Single-Cell Multi-Omics Market Segmentation
Figure 6: Global Single-Cell Multi-Omics Market: Research Methodology
Figure 7: Primary Research Methodology
Figure 8: Bottom-Up Approach (Segment-Wise Analysis)
Figure 9: Top-Down Approach (Segment-Wise Analysis)
Figure 10: Global Single-Cell Multi-Omics Market, Patent Analysis (by Country), January 2018- March 2023
Figure 11: Global Single-Cell Multi-Omics Market, Patent Analysis (by Year), January 2018-December2022
Figure 12: Global Single-Cell Multi-Omics Market, Key Trends, Market Shift, 2022-2033
Figure 13: Global Single-Cell Multi-Omics Market, Impact Analysis
Figure 14: Global Data for Rare Diseases, 2020
Figure 15: Companies Using Multi-Omics Approach in Research and Development of Drugs and Vaccines
Figure 16: Advantages of Multi-Omics in Drug Discovery and Development
Figure 17: Cost of Single Cell Sequencing (by Company)
Figure 18: Some of the Advancements in Single-Cell Metabolomics
Figure 19: Global Single-Cell Multi-Omics Market (by Product Type)
Figure 20: Global Single-Cell Multi-Omics Market, Incremental Opportunity (by Product Type), $Billion, 2023-2033
Figure 21: Global Single-Cell Multi-Omics Market (Instruments), $Billion, 2022-2033
Figure 22: Global Single-Cell Multi-Omics Market (Kits and Consumables), $Billion, 2022-2033
Figure 23: Global Single-Cell Multi-Omics Market (Software), $Billion, 2022-2033
Figure 24: Global Single-Cell Multi-Omics Market (by Sample Type)
Figure 25: Global Single-Cell Multi-Omics Market, Incremental Opportunity (by Sample Type), $Billion, 2023-2033
Figure 26: Global Single-Cell Multi-Omics Market (Human Samples), $Billion, 2022-2033
Figure 27: Global Single-Cell Multi-Omics Market (Cancer Tissues), $Million, 2022-2033
Figure 28: Global Single-Cell Multi-Omics Market (Stem Cells), $Million, 2022-2033
Figure 29: Global Single-Cell Multi-Omics Market (Brain Cells), $Million, 2022-2033
Figure 30: Global Single-Cell Multi-Omics Market (Immune Cells), $Million, 2022-2033
Figure 31: Global Single-Cell Multi-Omics Market (Other Samples), $Million, 2022-2033
Figure 32: Global Single-Cell Multi-Omics Market (Animal Samples), $Billion, 2022-2033
Figure 33: Global Single-Cell Multi-Omics Market (Microbial Samples), $Billion, 2022-2033
Figure 34: Global Single-Cell Multi-Omics Market (by Technique)
Figure 35: Global Single-Cell Multi-Omics Market, Incremental Opportunity (by Technique), $Billion, 2023-2033
Figure 36: Global Single-Cell Multi-Omics Market (Single-Cell Isolation and Dispensing), $Billion, 2022-2033
Figure 37: Global Single-Cell Multi-Omics Market (Fluorescence-Activated Cell Sorting (FACS)), $Million, 2022-2033
Figure 38: Global Single-Cell Multi-Omics Market (Manual Cell Picking), $Million, 2022-2033
Figure 39: Global Single-Cell Multi-Omics Market (Magnetic-Activated Cell Sorting (MACS)), $Million, 2022-2033
Figure 40: Global Single-Cell Multi-Omics Market (Laser Capture Microdissection), $Million, 2022-2033
Figure 41: Global Single-Cell Multi-Omics Market (Random Seeding), $Million, 2022-2033
Figure 42: Global Single-Cell Multi-Omics Market (Microfluidics), $Million, 2022-2033
Figure 43: Global Single-Cell Multi-Omics Market (Others), $Million, 2022-2033
Figure 44: Global Single-Cell Multi-Omics Market (Single-Cell Analysis), $Billion, 2022-2033
Figure 45: Global Single-Cell Multi-Omics Market (Mass Cytometry), $Million, 2022-2033
Figure 46: Global Single-Cell Multi-Omics Market (Polymerase Chain Reaction), $Million, 2022-2033
Figure 47: Global Single-Cell Multi-Omics Market (Next-Generation Sequencing), $Million, 2022-2033
Figure 48: Global Single-Cell Multi-Omics Market (Mass Spectrometry), $million, 2022-2033
Figure 49: Global Single-Cell Multi-Omics Market (Others), $Million, 2022-2033
Figure 50: Global Single-Cell Multi-Omics Market (by Application)
Figure 51: Global Single-Cell Multi-Omics Market, Incremental Opportunity (by Application), $Billion, 2023-2033
Figure 52: Global Single-Cell Multi-Omics Market (Clinical Research), $Billion, 2022-2033
Figure 53: Global Single-Cell Multi-Omics Market (Oncology), $Million, 2022-2033
Figure 54: Global Single-Cell Multi-Omics Market (Immunology), $Million, 2022-2033
Figure 55: Global Single-Cell Multi-Omics Market (Neurology), $Million, 2022-2033
Figure 56: Global Single-Cell Multi-Omics Market (Cell Therapy), $Million, 2022-2033
Figure 57: Global Single-Cell Multi-Omics Market (Cell Biology), $Million, 2022-2033
Figure 58: Global Single-Cell Multi-Omics Market (Others), $Million, 2022-2033
Figure 59: Global Single-Cell Multi-Omics Market (Translational Research), $Billion, 2022-2033
Figure 60: Global Single-Cell Multi-Omics Market (Synthetic Biology), $Billion, 2022-2033
Figure 61: Global Single-Cell Multi-Omics Market (by Omics Type)
Figure 62: Global Single-Cell Multi-Omics Market, Incremental Opportunity (by Omics Type), $Billion, 2023-2033
Figure 63: Global Single-Cell Multi-Omics Market (Single-Cell Genomics), $Billion, 2022-2033
Figure 64: Global Single-Cell Multi-Omics Market (Single-Cell Proteomics), $Billion, 2022-2033
Figure 65: Global Single-Cell Multi-Omics Market (Single-Cell Transcriptomics), $Billion, 2022-2033
Figure 66: Global Single-Cell Multi-Omics Market (by End User)
Figure 67: Global Single-Cell Multi-Omics Market, Incremental Opportunity (by End User), $Billion, 2023-2033
Figure 68: Global Single-Cell Multi-Omics Market (Biopharmaceutical and Biotech Companies), $Billion, 2022-2033
Figure 69: Global Single-Cell Multi-Omics Market (Research and Academic Laboratories), $Billion, 2022-2033
Figure 70: Global Single-Cell Multi-Omics Market (Contract Research Organizations (CROs)), $Billion, 2022-2033
Figure 71: Global Single-Cell Multi-Omics Market Share (by Region)
Figure 72: North America Single-Cell Multi-Omics Market, Incremental Opportunity (by Country), $Million, 2023-2033
Figure 73: North America Single-Cell Multi-Omics Market, $Billion, 2022-2033
Figure 74: North America Single-Cell Multi-Omics Market (by Country), % Share, 2022 and 2033
Figure 75: U.S. Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 76: Canada Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 77: Europe Single-Cell Multi-Omics Market, Incremental Opportunity (by Country), $Million, 2023-2033
Figure 78: Europe Single-Cell Multi-Omics Market, $Billion, 2022-2033
Figure 79: Europe Single-Cell Multi-Omics Market (by Country), % Share, 2022 and 2033
Figure 80: Germany Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 81: Italy Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 82: U.K. Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 83: Spain Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 84: France Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 85: Rest-of-Europe Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 86: Asia-Pacific Single-Cell Multi-Omics Market Incremental Revenue Opportunity (by Country), $Million, 2023-2033
Figure 87: Asia-Pacific Single-Cell Multi-Omics Market, $Billion, 2022-2033
Figure 88: Asia-Pacific Single-Cell Multi-Omics Market (by Country), % Share, 2022 and 2033
Figure 89: China Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 90: Japan Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 91: India Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 92: Singapore Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 93: Australia Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 94: Rest-of-Asia-Pacific Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 95: Latin America Single-Cell Multi-Omics Market Incremental Revenue Opportunity (by Country), $Million, 2022-2033
Figure 96: Latin America Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 97: Brazil Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 98: Mexico Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 99: Rest-of-Latin America Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 100: Rest-of-the-World Single-Cell Multi-Omics Market, $Million, 2022-2033
Figure 101: Global Single-Cell Multi-Omics Market, Number of Key Developments and Strategies, January 2018-March 2023
Figure 102: Funding Activities, January 2018-March 2023
Figure 103: New Offerings, January 2018-March 2023
Figure 104: Mergers and Acquisitions, January 2018-March 2023
Figure 105: Partnership, Collaboration, and Business expansion, January 2018-March 2023
Figure 106: Global Single-Cell Multi-Omics Market, Company Revenue Share Analysis, $Billion, 2022
Figure 107: Global Single-Cell Multi-Omics Market, Growth-Share Matrix (by Application), 2023-2033
Figure 108: Global Single-Cell Multi-Omics Market, Growth-Share Matrix (by Omics Type), 2023-2033
Figure 109: Global Single-Cell Multi-Omics Market, Growth-Share Matrix (by Product Type), 2023-2033
Figure 110: Global Single Cell Multi Omics Market, Visual Graphics of the Companies
Figure 111: 10x Genomics, Inc.: Product Portfolio
Figure 112: 10x Genomics, Inc.: Overall Financials, $Million, 2020-2022
Figure 113: 10x Genomics, Inc. Net Revenue (by Segment), $Million, 2020-2022
Figure 114: 10x Genomics, Inc.: Net Revenue (by Region), $Million, 2020-2022
Figure 115: 10x Genomics, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 116: Becton, Dickinson and Company: Product Portfolio
Figure 117: Becton, Dickinson and Company: Overall Financials, $Million, 2020-2022
Figure 118: Becton, Dickinson and Company: Net Revenue (by Segment), $Million, 2020-2022
Figure 119: Becton, Dickinson and Company: Net Revenue (by Region), $Million, 2020-2022
Figure 120: Becton, Dickinson and Company: R&D Expenditure, $Million, 2020-2022
Figure 121: BICO GROUP AB (PUBL): Product Portfolio
Figure 122: BICO GROUP AB (PUBL): Overall Financials, $Million, 2020-2022
Figure 123: BICO GROUP AB (PUBL): Net Revenue (by Segment), $Million, 2021 and 2022
Figure 124: BICO GROUP AB (PUBL): Net Revenue (by Region), $Million, 2020-2022
Figure 125: Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 126: Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2020-2022
Figure 127: Bio-Rad Laboratories, Inc.: Net Revenue (by Segment), $Million, 2020-2022
Figure 128: Bio-Rad Laboratories, Inc.: Net Revenue (by Region), $Million, 2020-2022
Figure 129: Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 130: BGI Genomics.: Product Portfolio
Figure 131: BGI Genomics: Overall Financials, $Million, 2020-2022
Figure 132: Illumina Inc.: Product Portfolio
Figure 133: Illumina Inc.: Overall Financials, $Million, 2020-2022
Figure 134: Illumina Inc.: Net Revenue (by Segment), $Million, 2020-2022
Figure 135: Illumina Inc.: Net Revenue (by Region), $Million, 2020-2022
Figure 136: Illumina, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 137: Fluidigm Corporation: Product Portfolio
Figure 138: Fluidigm Corporation: Overall Financials, $Million, 2020-2022
Figure 139: Fluidigm Corporation: Net Revenue (by Segment), $Million, 2020-2022
Figure 140: Fluidigm Corporation: Net Revenue (by Region), $Million, 2020-2022
Figure 141: Fluidigm Corporation: R&D Expenditure, $Million, 2020-2022
Figure 142: Menarini Silicon Biosystems: Product Portfolio
Figure 143: Mission Bio: Product Portfolio
Figure 144: Nanostring Technologies, Inc.: Product Portfolio
Figure 145: Nanostring Technologies, Inc.: Overall Financials, $Million, 2020-2022
Figure 146: Nanostring Technologies, Inc.: Net Revenue (by Region), $Million, 2020-2022
Figure 147: Nanostring Technologies, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 148: Namocell, Inc.: Product Portfolio
Figure 149: PhenomeX,inc.: Product Portfolio
Figure 150: PhenomeX,inc.: Overall Financials, $Million, 2020-2022
Figure 151: PhenomeX,inc.: Net Revenue (by Region), $Million, 2020-2022
Figure 152: PhenomeX,inc.: R&D Expenditure, $Million, 2020-2022
Figure 153: QIAGEN NV: Product Portfolio
Figure 154: QIAGEN NV: Overall Financials, $Million, 2020-2022
Figure 155: QIAGEN NV: Net Revenue (by Segment), $Million, 2020-2022
Figure 156: QIAGEN NV: Net Revenue (by Region), $Million, 2020-2022
Figure 157: QIAGEN NV: R&D Expenditure, $Million, 2020-2020
Figure 158: Rarecells Diagnostics: Product Portfolio
Figure 159: Scipio Bioscience: Product Portfolio
Figure 160: Shilps Sciences: Product Portfolio
Figure 161: Singleron Biotechnologies: Product Portfolio
Figure 162: Takara Bio Inc.: Product Portfolio
Figure 163: Takara Bio Inc.: Overall Financials, $Million, 2020-2022
Figure 164: Takara Bio Inc.: Net Revenue (by Segment), $Million, 2020-2022
Figure 165: Takara Bio Inc.: Net Revenue (by Region), $Million, 2020-2022
Figure 166: Takara Bio Inc.: R&D Expenditure, $Million, 2020-2022
Figure 167: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 168: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2020-2022
Figure 169: Thermo Fisher Scientific Inc.: Net Revenue (by Segment), $Million, 2020-2022
Figure 170: Thermo Fisher Scientific Inc.: Net Revenue (by Region), $Million, 2020-2022
Figure 171: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2020-2022
Figure 172: Universal Sequencing Technology Corporation: Product Portfolio
List of Tables
Table 1: Global Single-Cell Multi-Omics Market, Key Developments Analysis, January 2018-March 2023
Table 2: Key Questions Answered in the Report
Table 3: Global Single-Cell Multi-Omics Market: Global Regulatory Organization
Table 4: Global Single-Cell Multi-Omics Market, Product Benchmarking
Table 5: Global Single-Cell Multi-Omics Market, Ongoing Clinical Trials
Table 6: Single-Cell Multi-Omics Platforms Used in the Diagnosis of Disease
Table 7: Recent Collaborations between Technology Providers and Life Sciences Companies
Table 8: Cancer Research with Single-Cell Multi-Omics Technologies
Table 9: Advantages of scRNA-seq Methods in Immunology Applications
Table 10: North America Single-Cell Multi-Omics Market, Impact Analysis
Table 11: Europe Single-Cell Multi-Omics Market Dynamics, Impact Analysis
Table 12: Asia-Pacific Single-Cell Multi-Omics Market Dynamics, Impact Analysis
Table 13: Latin America Single-Cell Multi-Omics Market Dynamics, Impact Analysis
Table 14: Rest-of-the-World Single-Cell Multi-Omics Market, Impact Analysis
Table 15: Multi-Omics Ecosystem Active Players

Press Release